ZimVie Inc. (Nasdaq: ZIMV), a leading global life sciences company in the dental market, has announced the completion of its Spine business’s sale to an affiliate of H.I.G. Capital. The deal, finalized for a total consideration of $375 million, includes $315 million in cash and a $60 million promissory note. It is the culmination of…